 | • レポートコード：C9J00696 • 出版社/出版日：Prof Research / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥450,000 (USD3,000) | ▷ お問い合わせ |
| Site License | ￥570,000 (USD3,800) | ▷ お問い合わせ |
| Global Site License | ￥750,000 (USD5,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 世界及び中国におけるアンチセンス及びRNAI治療市場について調査・分析したレポートで、アンチセンス及びRNAI治療の世界市場動向、市場規模、主要企業情報などが含まれています。アンチセンス及びRNAI治療の種類別には、RNAインタフェア、SiRNA、MiRNA、アンチセンスRNAに分けて分析し、地域別には、アメリカ、ヨーロッパ、日本、中国などに区分してまとめてあります。 ・アンチセンス及びRNAI治療産業の概要 ・アンチセンス及びRNAI治療の製造技術分析 ・主要企業分析：企業概要、製品情報、連絡先など ・世界及び中国のアンチセンス及びRNAI治療市場 2014年-2019年 ・世界及び中国のアンチセンス及びRNAI治療市場現状 ・企業別分析：Alnylam Pharmaceuticals, Isis Pharmaceuticals, Sanofi, Glaxosmithkline, Pfizer, Allergan, Antisense Therapeutics, Ascletis, AstraZeneca, Novartis, Atlantic Pharmaceuticals, Benitec Biopharma, Biogen Iなど ・地域別分析：アメリカ、ヨーロッパ、日本、中国など ・種類別分析：RNAインタフェア、SiRNA、MiRNA、アンチセンスRNA ・世界及び中国のアンチセンス及びRNAI治療市場予測 2019年-2024年 ・アンチセンス及びRNAI治療の産業チェーン分析 ・世界及び中国のマクロ経済動向と影響 ・世界及び中国のアンチセンス及びRNAI治療市場動向・課題・機会 ・新規プロジェクトへの提言・結論 |
Antisense and RNAi Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Antisense and RNAi Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Antisense and RNAi Therapeutics manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Antisense and RNAi Therapeutics market covering all important parameters.
The key ponits of the report:
1.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
2.The report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company.
3.Through the statistical analysis, the report depicts the global and Chinese total market of Antisense and RNAi Therapeutics industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report then estimates 2019-2024 market development trends of Antisense and RNAi Therapeutics industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.
6.The report makes some important proposals for a new project of Antisense and RNAi Therapeutics Industry before evaluating its feasibility.
There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.
For competitor segment, the report includes global key players of Antisense and RNAi Therapeutics as well as some small players. At least 13 companies are included:
* Alnylam Pharmaceuticals
* Isis Pharmaceuticals
* Sanofi
* Glaxosmithkline
* Pfizer
* Allergan
For complete companies list, please ask for sample pages.
The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share
For product type segment, this report listed main product type of Antisense and RNAi Therapeutics market in gloabal and china.
* RNA interference
* SiRNA
* MiRNA
* Antisense RNA
For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.
* Application I
* Application II
* Application III
Reasons to Purchase this Report:
* Estimates 2019-2024 Antisense and RNAi Therapeutics market development trends with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.
Any special requirements about this report, please let us know and we can provide custom report.
レポート目次Chapter One Introduction of Antisense and RNAi Therapeutics Industry
1.1 Brief Introduction of Antisense and RNAi Therapeutics
1.2 Development of Antisense and RNAi Therapeutics Industry
1.3 Status of Antisense and RNAi Therapeutics Industry
Chapter Two Manufacturing Technology of Antisense and RNAi Therapeutics
2.1 Development of Antisense and RNAi Therapeutics Manufacturing Technology
2.2 Analysis of Antisense and RNAi Therapeutics Manufacturing Technology
2.3 Trends of Antisense and RNAi Therapeutics Manufacturing Technology
Chapter Three Analysis of Global Key Manufacturers
3.1 Alnylam Pharmaceuticals
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 2014-2019 Production Information
3.1.4 Contact Information
3.2 Isis Pharmaceuticals
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 2014-2019 Production Information
3.2.4 Contact Information
3.3 Sanofi
3.2.1 Company Profile
3.3.2 Product Information
3.3.3 2014-2019 Production Information
3.3.4 Contact Information
3.4 Glaxosmithkline
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 2014-2019 Production Information
3.4.4 Contact Information
3.5 Pfizer
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 2014-2019 Production Information
3.5.4 Contact Information
3.6 Allergan
3.6.1 Company Profile
3.6.2 Product Information
3.5.3 2014-2019 Production Information
3.6.4 Contact Information
3.7 Antisense Therapeutics
3.7.1 Company Profile
3.7.2 Product Information
3.7.3 2014-2019 Production Information
3.7.4 Contact Information
3.8 Company H
3.8.1 Company Profile
3.8.2 Product Information
3.8.3 2014-2019 Production Information
3.8.4 Contact Information
……
……
Chapter Four 2014-2019 Global and Chinese Market of Antisense and RNAi Therapeutics
4.1 2014-2019 Global Capacity, Production and Production Value of Antisense and RNAi Therapeutics Industry
4.2 2014-2019 Global Cost and Profit of Antisense and RNAi Therapeutics Industry
4.3 Market Comparison of Global and Chinese Antisense and RNAi Therapeutics Industry
4.4 2014-2019 Global and Chinese Supply and Consumption of Antisense and RNAi Therapeutics
4.5 2014-2019 Chinese Import and Export of Antisense and RNAi Therapeutics
Chapter Five Market Status of Antisense and RNAi Therapeutics Industry
5.1 Market Competition of Antisense and RNAi Therapeutics Industry by Company
5.2 Market Competition of Antisense and RNAi Therapeutics Industry by Country (USA, EU, Japan, Chinese etc.)
5.3 Market Analysis of Antisense and RNAi Therapeutics Consumption by Application/Type
Chapter Six 2019-2024 Market Forecast of Global and Chinese Antisense and RNAi Therapeutics Industry
6.1 2019-2024 Global and Chinese Capacity, Production, and Production Value of Antisense and RNAi Therapeutics
6.2 2019-2024 Antisense and RNAi Therapeutics Industry Cost and Profit Estimation
6.3 2019-2024 Global and Chinese Market Share of Antisense and RNAi Therapeutics
6.4 2019-2024 Global and Chinese Supply and Consumption of Antisense and RNAi Therapeutics
6.5 2019-2024 Chinese Import and Export of Antisense and RNAi Therapeutics
Chapter Seven Analysis of Antisense and RNAi Therapeutics Industry Chain
7.1 Industry Chain Structure
7.2 Upstream Raw Materials
7.3 Downstream Industry
Chapter Eight Global and Chinese Economic Impact on Antisense and RNAi Therapeutics Industry
8.1 Global and Chinese Macroeconomic Environment Analysis
8.1.1 Global Macroeconomic Analysis
8.1.2 Chinese Macroeconomic Analysis
8.2 Global and Chinese Macroeconomic Environment Development Trend
8.2.1 Global Macroeconomic Outlook
8.2.2 Chinese Macroeconomic Outlook
8.3 Effects to Antisense and RNAi Therapeutics Industry
Chapter Nine Market Dynamics of Antisense and RNAi Therapeutics Industry
9.1 Antisense and RNAi Therapeutics Industry News
9.2 Antisense and RNAi Therapeutics Industry Development Challenges
9.3 Antisense and RNAi Therapeutics Industry Development Opportunities
Chapter Ten Proposals for New Project
10.1 Market Entry Strategies
10.2 Countermeasures of Economic Impact
10.3 Marketing Channels
10.4 Feasibility Studies of New Project Investment
Chapter Eleven Research Conclusions of Global and Chinese Antisense and RNAi Therapeutics Industry
Tables and Figures
Figure Antisense and RNAi Therapeutics Product Picture
Table Development of Antisense and RNAi Therapeutics Manufacturing Technology
Figure Manufacturing Process of Antisense and RNAi Therapeutics
Table Trends of Antisense and RNAi Therapeutics Manufacturing Technology
Figure Antisense and RNAi Therapeutics Product and Specifications
Table 2014-2019 Antisense and RNAi Therapeutics Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Antisense and RNAi Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Antisense and RNAi Therapeutics Production Global Market Share
Figure Antisense and RNAi Therapeutics Product and Specifications
Table 2014-2019 Antisense and RNAi Therapeutics Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Antisense and RNAi Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Antisense and RNAi Therapeutics Production Global Market Share
Figure Antisense and RNAi Therapeutics Product and Specifications
Table 2014-2019 Antisense and RNAi Therapeutics Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Antisense and RNAi Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Antisense and RNAi Therapeutics Production Global Market Share
Figure Antisense and RNAi Therapeutics Product and Specifications
Table 2014-2019 Antisense and RNAi Therapeutics Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Antisense and RNAi Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Antisense and RNAi Therapeutics Production Global Market Share
Figure Antisense and RNAi Therapeutics Product and Specifications
Table 2014-2019 Antisense and RNAi Therapeutics Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Antisense and RNAi Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Antisense and RNAi Therapeutics Production Global Market Share
Figure Antisense and RNAi Therapeutics Product and Specifications
Table 2014-2019 Antisense and RNAi Therapeutics Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Antisense and RNAi Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Antisense and RNAi Therapeutics Production Global Market Share
Figure Antisense and RNAi Therapeutics Product and Specifications
Table 2014-2019 Antisense and RNAi Therapeutics Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Antisense and RNAi Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Antisense and RNAi Therapeutics Production Global Market Share
Figure Antisense and RNAi Therapeutics Product and Specifications
Table 2014-2019 Antisense and RNAi Therapeutics Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Antisense and RNAi Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Antisense and RNAi Therapeutics Production Global Market Share
……
……
Table 2014-2019 Global Antisense and RNAi Therapeutics Capacity List
Table 2014-2019 Global Antisense and RNAi Therapeutics Key Manufacturers Capacity Share List
Figure 2014-2019 Global Antisense and RNAi Therapeutics Manufacturers Capacity Share
Table 2014-2019 Global Antisense and RNAi Therapeutics Key Manufacturers Production List
Table 2014-2019 Global Antisense and RNAi Therapeutics Key Manufacturers Production Share List
Figure 2014-2019 Global Antisense and RNAi Therapeutics Manufacturers Production Share
Figure 2014-2019 Global Antisense and RNAi Therapeutics Capacity Production and Growth Rate
Table 2014-2019 Global Antisense and RNAi Therapeutics Key Manufacturers Production Value List
Figure 2014-2019 Global Antisense and RNAi Therapeutics Production Value and Growth Rate
Table 2014-2019 Global Antisense and RNAi Therapeutics Key Manufacturers Production Value Share List
Figure 2014-2019 Global Antisense and RNAi Therapeutics Manufacturers Production Value Share
Table 2014-2019 Global Antisense and RNAi Therapeutics Capacity Production Cost Profit and Gross Margin List
Figure 2014-2019 Chinese Share of Global Antisense and RNAi Therapeutics Production
Table 2014-2019 Global Supply and Consumption of Antisense and RNAi Therapeutics
Table 2014-2019 Import and Export of Antisense and RNAi Therapeutics
Figure 2018 Global Antisense and RNAi Therapeutics Key Manufacturers Capacity Market Share
Figure 2018 Global Antisense and RNAi Therapeutics Key Manufacturers Production Market Share
Figure 2018 Global Antisense and RNAi Therapeutics Key Manufacturers Production Value Market Share
Table 2014-2019 Global Antisense and RNAi Therapeutics Key Countries Capacity List
Figure 2014-2019 Global Antisense and RNAi Therapeutics Key Countries Capacity
Table 2014-2019 Global Antisense and RNAi Therapeutics Key Countries Capacity Share List
Figure 2014-2019 Global Antisense and RNAi Therapeutics Key Countries Capacity Share
Table 2014-2019 Global Antisense and RNAi Therapeutics Key Countries Production List
Figure 2014-2019 Global Antisense and RNAi Therapeutics Key Countries Production
Table 2014-2019 Global Antisense and RNAi Therapeutics Key Countries Production Share List
Figure 2014-2019 Global Antisense and RNAi Therapeutics Key Countries Production Share
Table 2014-2019 Global Antisense and RNAi Therapeutics Key Countries Consumption Volume List
Figure 2014-2019 Global Antisense and RNAi Therapeutics Key Countries Consumption Volume
Table 2014-2019 Global Antisense and RNAi Therapeutics Key Countries Consumption Volume Share List
Figure 2014-2019 Global Antisense and RNAi Therapeutics Key Countries Consumption Volume Share
Figure 78 2014-2019 Global Antisense and RNAi Therapeutics Consumption Volume Market by Application
Table 89 2014-2019 Global Antisense and RNAi Therapeutics Consumption Volume Market Share List by Application
Figure 79 2014-2019 Global Antisense and RNAi Therapeutics Consumption Volume Market Share by Application
Table 90 2014-2019 Chinese Antisense and RNAi Therapeutics Consumption Volume Market List by Application
Figure 80 2014-2019 Chinese Antisense and RNAi Therapeutics Consumption Volume Market by Application
Figure 2019-2024 Global Antisense and RNAi Therapeutics Capacity Production and Growth Rate
Figure 2019-2024 Global Antisense and RNAi Therapeutics Production Value and Growth Rate
Table 2019-2024 Global Antisense and RNAi Therapeutics Capacity Production Cost Profit and Gross Margin List
Figure 2019-2024 Chinese Share of Global Antisense and RNAi Therapeutics Production
Table 2019-2024 Global Supply and Consumption of Antisense and RNAi Therapeutics
Table 2019-2024 Import and Export of Antisense and RNAi Therapeutics
Figure Industry Chain Structure of Antisense and RNAi Therapeutics Industry
Figure Production Cost Analysis of Antisense and RNAi Therapeutics
Figure Downstream Analysis of Antisense and RNAi Therapeutics
Table Growth of World output, 2014 – 2019, Annual Percentage Change
Figure Unemployment Rates in Selected Developed Countries, January 2014 – March 2018
Figure Nominal Effective Exchange Rate: Japan and Selected Emerging Economies, September 2014-March 2018
Figure 2014-2019 Chinese GDP and Growth Rates
Figure 2014-2019 Chinese CPI Changes
Figure 2014-2019 Chinese PMI Changes
Figure 2014-2019 Chinese Financial Revenue and Growth Rate
Figure 2014-2019 Chinese Total Fixed Asset Investment and Growth Rate
Figure 2019-2024 Chinese GDP and Growth Rates
Figure 2019-2024 Chinese CPI Changes
Table Economic Effects to Antisense and RNAi Therapeutics Industry
Table Antisense and RNAi Therapeutics Industry Development Challenges
Table Antisense and RNAi Therapeutics Industry Development Opportunities
Figure Map of Chinese 33 Provinces and Administrative Regions
Table Selected Cities According to Industrial Orientation
Figure Chinese IPR Strategy
Table Brief Summary of Suggestions
Table New Antisense and RNAi Therapeuticss Project Feasibility Study
RNA干渉(RNAi)ドラッグデリバリー市場：世界及び中国市場分析・予測（～2024年） RNA Interference (RNAi) Drug Delivery Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global RNA Interference (RNAi) Drug Delivery industry with a focus on the Chinese market. The report provides key statistics on the market status o…- 増殖糖尿病網膜症治療法市場：世界及び中国の市場分析・予測（～2024年） Proliferative Diabetic Retinopathy Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Proliferative Diabetic Retinopathy Therapeutics industry with a focus on the Chinese market. The report provides key statistics on…
- 世界のサンドホフ病治療薬市場2019 The global Sandhoff Disease Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Sandhoff Disease Therapeutics market status and forecast, categorizes the global Sandhoff Disease The…
- 世界の骨粗鬆症治療薬市場：市場規模・現状・予測 Osteoporosis is a disease where decreased bone strength increases the risk of a broken bone. It is the most common reason for a broken bone among the elderly. Bones that commonly break include the back bones, the bones of the forearm, and the hip. Until a broken bone occurs there are typically no sy…
- 世界の過活動膀胱治療学市場：市場規模・現状・予測 Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).North America is the largest consumption market of Overactive B…